Auris Health company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

aurishealth.com

Total Raised

$733.29M

Investors Count

10

Deal Terms

5

Investments

1

Auris Health Funding, Auris Health Valuation & Auris Health Revenue

7 Fundings

Auris Health's latest funding round was a Acquired for on February 13, 2019.

Auris Health's valuation in August 2017 was $1,280M.

Auris Health's latest post-money valuation is from February 2019.

Sign up for a free trial to see Auris Health's valuations in February 2019, September 2015 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

2/13/2019

Acquired

$99M

0

FY undefined

7

11/28/2018

Series E

$99M

0

FY undefined

10

8/4/2017

Series D

$99M

$1,280M

0

FY undefined

10

8/9/2016

Series C

$99M

0

FY undefined

10

9/23/2015

Series B

$99M

$99M

0

FY undefined

10

Date

2/13/2019

11/28/2018

8/4/2017

8/9/2016

9/23/2015

Round

Acquired

Series E

Series D

Series C

Series B

Amount

$99M

$99M

$99M

$99M

Investors

Valuation

$99M

$1,280M

$99M

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

7

10

10

10

10

Auris Health Deal Terms

5 Deal Terms

Auris Health's deal structure is available for 5 funding rounds, including their Acquired from February 13, 2019.

Round

Acquired

Series D

Series C

Series B

Series A

Funding Date

$99M

$99M

$99M

$99M

$99M

Pre-Money Valuation

$99M

Post-Money Valuation

$99M

$99M

Amount Raised

$99M

$99M

$99M

$99M

Shares Authorized

Issuance Price

$99M

$99M

$99M

Dividend Rate

$99M

$99M

$99M

Liquidation Preferences

$99M

$99M

$99M

Liquidation Price

Participation

Conversion Price

Anti Dilution

$99M

$99M

$99M

General Voting

$99M

$99M

$99M

$99M

$99M

Board Voting

$99M

$99M

$99M

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Acquired

$99M

$99M

$99M

$99M

Series D

$99M

$99M

$99M

$99M

$99M

$99M

Series C

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series B

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series A

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Auris Health Investors

10 Investors

Auris Health has 10 investors. Johnson & Johnson invested in Auris Health's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

2/13/2019

2/13/2019

1
Acquired

Corporation

New Jersey

3/31/2014

11/28/2018

5
Series A, Series B (2015), Series C (2016), Series D (2017), Series E (2018)

Venture Capital

Texas

3/31/2014

11/28/2018

5
Series A, Series B (2015), Series C (2016), Series D (2017), Series E (2018)

Venture Capital

New York

00/00/0000

00/00/0000

Wellington Management

Subscribe to see more

Asset/Investment Management

Massachusetts

00/00/0000

00/00/0000

PFM Health Sciences

Subscribe to see more

Venture Capital

California

First funding

2/13/2019

3/31/2014

3/31/2014

00/00/0000

00/00/0000

Last Funding

2/13/2019

11/28/2018

11/28/2018

00/00/0000

00/00/0000

Investor

Wellington Management

PFM Health Sciences

Rounds

1
Acquired
5
Series A, Series B (2015), Series C (2016), Series D (2017), Series E (2018)
5
Series A, Series B (2015), Series C (2016), Series D (2017), Series E (2018)

Subscribe to see more

Subscribe to see more

Board Seats

Type

Corporation

Venture Capital

Venture Capital

Asset/Investment Management

Venture Capital

Location

New Jersey

Texas

New York

Massachusetts

California

Auris Health Acquisitions

1 Acquisition

Auris Health acquired 1 company. Their latest acquisition was Hansen Medical on April 20, 2016.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

4/20/2016

Other Venture Capital

$99M

$57.8M

Acquired

5

Date

4/20/2016

Investment Stage

Other Venture Capital

Companies

Valuation

$99M

Total Funding

$57.8M

Note

Acquired

Sources

5

Auris Health Investments

1 Investments

Auris Health has made 1 investments. Their latest investment was in Qool Therapeutics as part of their Series B on November 11, 2017.

CBI Logo

Auris Health Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

11/8/2017

Series B

Qool Therapeutics

$13.96M

Yes

1

Date

11/8/2017

Round

Series B

Company

Qool Therapeutics

Amount

$13.96M

New?

Yes

Co-Investors

Sources

1

You May Also Like

M
Medrobotics

Medrobotics has developed a platform of flexible medical robots that enable surgeons to access, visualize, and perform two-handed surgery in hard-to-reach anatomical places through a single-site access. The core technology is a new generation of flexible robotic snakes with advanced vision systems that are able to navigate tortuous paths while providing accessory channels for a wide range of flexible surgical tools. The robots are self-supporting, which means they are able to support their own weight and move within any three-dimensional space without the need for any other structural support. The company was formerly known as Cardiorobotics and Innvoention Technologies.

CMR Surgical Logo
CMR Surgical

CMR Surgical is a surgical robotics company developing universal robotic systems for minimal access surgery. The company's vision is to make minimal access (or keyhole) surgery universally accessible and affordable by significantly expanding the range of procedures that can be performed robotically.

A
ACTIV Surgical

Activ is a developer of software to augment surgeons. It develops an AI/ML platform called ActivEdge, which is designed to provide real-time intelligence and visualization to surgeons. The company was founded in 2017 and is based in Boston, Massachusetts.

Quantum Surgical Logo
Quantum Surgical

Quantum Surgical is a surgical robotics start-up building next-generation smart tools for minimally invasive therapies, beginning with interventional oncology. The robotic platform will enable physicians to better assess, plan, and treat a broad spectrum of medical conditions. The Company is developing end-to-end solutions for interventional oncology.

I
Intuitive Surgical

Intuitive Surgical develops, manufactures and markets robotic surgical systems under the da Vinci Surgical brand.

Theator Logo
Theator

Theator offers an online platform where surgeons can record surgeries and use them as educational material for improving future procedures. It was founded in 2018 and is based in Palo Alto, California.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.